Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble

About this trial

The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.

DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.

The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.

Then, the main question is:

is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.

Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.

Eligibility criteria

Qualifiers

Patient with an inflammatory bowel disease according to gastroenterologist

Disqualifiers

No exclusion criteria

Difficulty for understanding or reading french

Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code

Patients with no social security coverage.

Trial design

Treatments tested in this trial

  • Screening questionnaire

Treatment groups

220 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Grenoble

Lead sponsor

Clinique des Cèdres, Echirolles

Collaborator